Nesapidil

This classification denotes a vasodilating agent with the molecular formula C23H28N4O4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier QRY8KPT3QI, chemically known as (rs)-1-(4-(2-methoxyphenyl)-1-piperazinyl)-3-(3-(5-methyl-1,3,4-oxadiazol-2-yl)phenoxy)-2-propanol but generally known as nesapidil, which bears US NIH Compound Identifier 175512. European Medicines Agency schedules Nesapidil in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09207MIG. The term NESAPIDIL is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 39, No. 5, 1985, List 25). NESAPIDIL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule nesapidil under HS 29349990 and SITC 51579. As of Q4 2014, NESAPIDIL remains the US FDA Preferred Term for this commodity. Nesapidil bears US NLM identifiers UMLS ID C1882067 and NCI Concept Code C66232. SMILES: OC(CN1CCN(CC1)c1c(OC)cccc1)COc1cc(ccc1)c1oc(nn1)C.